Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and pharmacokinetics of peripheral intravenous posaconazole in healthy volunteers
NL-OMON36291Active, not recruiting
- Sponsor
- Merck & Co.
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of posaconazole in mycoses, sponsored by Merck & Co. Primary endpoint: Safety and tolerability. Started Sep 2010; status: active, not recruiting.
02
Drugs
posaconazole
03
Conditions
mycoses
Beyond the preview
Go deeper on NL-OMON36291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36291.